Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients. 1995

D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
Faculty of Medicine, University of Western Ontario, London, Canada.

Trough concentrations of cyclosporine can be highly variable because of its poor bioavailability in current oral formulations, Sandimmune (SIM). Neoral (N-SIM) a new microemulsion of cyclosporine is more readily absorbed than SIM in healthy controls. The present study compared the pharmacokinetic profiles of SIM and N-SIM following orthotopic liver transplantation. In 16 patients with partial biliary diversion, 1 week after transplantation, the bioavailability and peak concentration of a single 300 mg dose of N-SIM were greater than SIM by 724% (p = 0.0019) and 800% (p = 0.0001), respectively. In 39 patients who were on stable doses of cyclosporine 1 month after transplantation, the bioavailability of N-SIM was higher than that of SIM under both fasting (+64%, p = 0.001) and fed (+37%, p = 0.004) conditions. Trough concentrations were similar for the two formulations. However, peak concentrations were higher for N-SIM in both fasting (+119%, p = 0.003) and fed (+53%, p = 0.003) patients. Also, time to peak was shorter for N-SIM in both fasting (-21%, p = 0.027) and fed (-59%, p = 0.0001) patients. The correlation between trough concentrations and bioavailability was greater for N-SIM than for SIM in fasted (r = 0.80, p = 0.0001 versus r = 0.75, p = 0.0001) and fed patients (r = 0.65; p = 0.002 versus r = 0.55; p = 0.012). We conclude that the rate of absorption and the bioavailability of N-SIM is significantly and consistently better than SIM and may, therefore, improve the therapeutic index of cyclosporine after liver transplantation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
October 1996, Transplantation,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
August 1996, Transplantation proceedings,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
October 1994, Transplantation proceedings,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
June 1997, Transplantation,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
January 1998, Pharmacotherapy,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
October 2006, Therapeutic drug monitoring,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
May 2000, Bone marrow transplantation,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
February 2004, The Annals of pharmacotherapy,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
October 1992, Bulletin de l'Academie nationale de medecine,
D Freeman, and D Grant, and G Levy, and J Rochon, and P Y Wong, and I Altraif, and S Asfar
January 1997, Transplantation proceedings,
Copied contents to your clipboard!